Clinical Trials for Trastuzumab emtansine (T-DM1)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCGI1283
02/14/2013
A Randomized, Multicenter, Adaptive Phase II/III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine (T-DM1) Versus Taxane (Docetaxel or Paclitaxel) in Patients with Previously Treated Locally Advanced or Metastatic HER2-Positive Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.